High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)
Titel:
High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)
Auteur:
Phelip, Jean Marc Mineur, Laurent Fouchardière, Christelle De la Chatelut, Etienne Quesada, Jean Louis Roblin, Xavier Pezet, Denis Mendoza, Christophe Buc, Emmanuel Rivoire, Michel